MDxHealth SA (MDXH)
1.88
+0.17
(+9.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.84
-0.04
(-2.13%)
After-Hours: 20:00
MDxHealth Net Income (Quarterly): -11.19M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.19M |
| June 30, 2024 | -11.53M |
| March 31, 2024 | -8.511M |
| December 31, 2023 | -10.72M |
| September 30, 2023 | -10.04M |
| June 30, 2023 | -10.63M |
| March 31, 2023 | -11.71M |
| Date | Value |
|---|---|
| December 31, 2022 | -12.44M |
| September 30, 2022 | -13.50M |
| June 30, 2022 | -9.834M |
| March 31, 2022 | -8.27M |
| December 31, 2021 | -8.082M |
| September 30, 2021 | -7.621M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-13.50M
Minimum
Sep 2022
-7.621M
Maximum
Sep 2021
-10.31M
Average
-10.63M
Median
Jun 2023
Net Income (Quarterly) Benchmarks
| Galapagos NV | -55.46M |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | -18.76M |
| Celyad Oncology SA | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 23.32M |
| Total Expenses (Quarterly) | 29.41M |
| EPS Diluted (Quarterly) | -0.40 |
| Enterprise Value | 95.14M |
| Gross Profit Margin (Quarterly) | 61.22% |
| Profit Margin (Quarterly) | -47.99% |
| Earnings Yield | -80.85% |
| Normalized Earnings Yield | -80.85 |